Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER).
María Jesús Garcia-VillanuevaSandra Garrote-CorralJose María Pego-ReigosaNorman Jiménez OteroEsther Uriarte IsazelaiaAlejandro OlivéClara Sangüesa GómezMercedes Freire GonzálezElena AurrecoecheaEnrique Raya ÁlvarezEva Tomero MurielCarlos Montilla MoralesMaría Galindo IzquierdoJaime Calvo AlénRaúl MenorBelén Serrano-BenaventeJulia Martinez-BarrioJose Angel Hernández-BeriainMónica Ibañez BarcelóGema Bonilla HernanJosé RosasEva Salgado PérezAntonio Fernandez-NebroÍñigo Rúa-FigueroaPublished in: Rheumatology international (2024)
DAH is rare in patients with SLE; in up to one-third of patients, it may appear at the onset of the disease. Some factors, such as smoking, a history of LN, treatment with cyclophosphamide, or concomitant infection, are more prevalent in patients with an unfavorable outcome.
Keyphrases
- systemic lupus erythematosus
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- low dose
- prognostic factors
- high dose
- patient reported outcomes
- big data
- electronic health record
- machine learning
- combination therapy
- artificial intelligence
- patient reported
- data analysis